These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2044590)

  • 1. 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment.
    Duran M; Wanders RJ; de Jager JP; Dorland L; Bruinvis L; Ketting D; Ijlst L; van Sprang FJ
    Eur J Pediatr; 1991 Jan; 150(3):190-5. PubMed ID: 2044590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary 3-hydroxydicarboxylic aciduria mimicking long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Bennett MJ; Weinberger MJ; Sherwood WG; Burlina AB
    J Inherit Metab Dis; 1994; 17(3):283-6. PubMed ID: 7807934
    [No Abstract]   [Full Text] [Related]  

  • 3. Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey.
    Gillingham M; Van Calcar S; Ney D; Wolff J; Harding C
    J Inherit Metab Dis; 1999 Apr; 22(2):123-31. PubMed ID: 10234607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked elevation of urinary 3-hydroxydecanedioic acid in a malnourished infant with glycogen storage disease, mimicking long-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency.
    Bergoffen J; Kaplan P; Hale DE; Bennett MJ; Berry GT
    J Inherit Metab Dis; 1993; 16(5):851-6. PubMed ID: 8295400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.
    Jones PM; Butt Y; Bennett MJ
    Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder.
    Sewell AC; Bender SW; Wirth S; Münterfering H; Ijlist L; Wanders RJ
    Eur J Pediatr; 1994 Oct; 153(10):745-50. PubMed ID: 7813533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria.
    Tserng KY; Jin SJ; Kerr DS; Hoppel CL
    Metabolism; 1991 Jul; 40(7):676-82. PubMed ID: 1870421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of hydroxydicarboxylic aciduria based on release of 3H2O from [9,10-3H]myristic and [9,10-3H]palmitic acids by intact cultured fibroblasts.
    Olpin SE; Manning NJ; Carpenter K; Middleton B; Pollitt RJ
    J Inherit Metab Dis; 1992; 15(6):883-90. PubMed ID: 1293385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondropathy presenting with non-ketotic hypoglycaemia as 3-hydroxydicarboxylic aciduria.
    Mayatepek E; Wanders RJ; Becker M; Bremer HJ; Hoffmann GF
    J Inherit Metab Dis; 1995; 18(2):249-52. PubMed ID: 7564260
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients.
    Tyni T; Palotie A; Viinikka L; Valanne L; Salo MK; von Döbeln U; Jackson S; Wanders R; Venizelos N; Pihko H
    J Pediatr; 1997 Jan; 130(1):67-76. PubMed ID: 9003853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
    MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S
    J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Hydroxydicarboxylic aciduria--a fatty acid oxidation defect with severe prognosis.
    Hagenfeldt L; von Döbeln U; Holme E; Alm J; Brandberg G; Enocksson E; Lindeberg L
    J Pediatr; 1990 Mar; 116(3):387-92. PubMed ID: 2308028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: different clinical expression in three unrelated patients.
    Wanders RJ; Ijlst L; Duran M; Jakobs C; de Klerk JB; Przyrembel H; Rocchiccioli F; Aubourg P
    J Inherit Metab Dis; 1991; 14(3):325-8. PubMed ID: 1770784
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcomes in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.
    Morris AA; Clayton PT; Surtees RA; Leonard JV
    J Pediatr; 1997 Dec; 131(6):938. PubMed ID: 9427908
    [No Abstract]   [Full Text] [Related]  

  • 15. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy.
    Sims HF; Brackett JC; Powell CK; Treem WR; Hale DE; Bennett MJ; Gibson B; Shapiro S; Strauss AW
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):841-5. PubMed ID: 7846063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Przyrembel H; Jakobs C; IJlst L; de Klerk JB; Wanders RJ
    J Inherit Metab Dis; 1991; 14(5):674-80. PubMed ID: 1779613
    [No Abstract]   [Full Text] [Related]  

  • 17. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood.
    Rocchiccioli F; Wanders RJ; Aubourg P; Vianey-Liaud C; Ijlst L; Fabre M; Cartier N; Bougneres PF
    Pediatr Res; 1990 Dec; 28(6):657-62. PubMed ID: 2284166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal diagnosis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and implications for newborn screening by tandem mass spectrometry.
    Carpenter KH; Wilcken B
    J Inherit Metab Dis; 1999 Oct; 22(7):840-1. PubMed ID: 10518286
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency--diagnosis, plasma carnitine fractions and management in a further patient.
    Moore R; Glasgow JF; Bingham MA; Dodge JA; Pollitt RJ; Olpin SE; Middleton B; Carpenter K
    Eur J Pediatr; 1993 May; 152(5):433-6. PubMed ID: 8319713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Gillingham MB; Connor WE; Matern D; Rinaldo P; Burlingame T; Meeuws K; Harding CO
    Mol Genet Metab; 2003 Jun; 79(2):114-23. PubMed ID: 12809642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.